• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION HANCOCK II BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION HANCOCK II BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number T505
Device Problems Structural Problem (2506); Insufficient Information (3190)
Patient Problems Aneurysm (1708); Stroke/CVA (1770); Endocarditis (1834); Regurgitation (2259); Blood Loss (2597); Thromboembolism (2654); Vascular Dissection (3160)
Event Date 01/01/2006
Event Type  Injury  
Manufacturer Narrative
Citation: borger et al.Twenty-year results of the hancock ii bioprosthesis.J heart valve dis.2006 jan;15(1):49-55.Earliest date of publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information, it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding 20-year results of hancock ii porcine bioprosthetic valve in a large patient population.All data were collected by mail and/or telephone questionnaire for patients who underwent surgery between 1982 and 2001.The study population included 1,569 patients (predominantly male, mean age 67 years), all of which were implanted with medtronic hancock ii porcine bioprosthetic valve in the atrial (1,010) or mitral (559) position.No serial numbers provided.Among all patients, adverse events included: thromboembolism/stroke/transient ischemic attack, endocarditis, major bleeding, structural valve dysfunction (svd), aneurysm/dissection, paravalvular leak, and valve-related reoperation.Based on the available information medtronic product may have been associated with the adverse event(s).No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HANCOCK II BIOPROSTHETIC HEART VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key8493306
MDR Text Key141307717
Report Number2025587-2019-01158
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
P980043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 04/08/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/08/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberT505
Device Catalogue NumberT505
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/01/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age67 YR
-
-